Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: mokelumne river	5/9/2016 12:08:32 PM
	Read Replies (1) of 2026

Listened to the call. Dr. Kim was a credible expert speaker. The clinical trial slides were probably too complicated for most investors. However, Kim presented the bottom lines and answered the "email questions" very well. That Kim provided assurances that Vitaros was the real deal from a medical standpoint was beneficial. A private investor, "Bill Clark," asked a question about delisting that Pascoe clearly did not want to spend time on. Pascoe can't exactly say that he expects the share price to rise above the delisting requirements based on the NDA submittal to the FDA in Q3, or that he expects a bail out by the Denners of the Apricus world.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next